Technology

Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.

Califf Seeks Evidence to Guide Regulatory Decisions

ByJill Wechsler, Pharm Exec’s Washington Correspondent

May 15th 2016

Pharmaceutical Executive

May 16, 2016.

Takeda Receives Grant from Bill & Melinda Gates Foundation

May 13th 2016

Pharmaceutical Executive

May 13, 2016.

Opdivo Will Help Boost Non-Small Cell Lung Cancer Market in Asia-Pac

May 6th 2016

May 06, 2016.

Experts Urge Caution in Expansion of Drug Development Incentive Program

May 5th 2016

May 05. 2016.

UK Cell and Gene Therapy Manufacturing Capability on the Rise

May 5th 2016

May 05, 2016.

Sanofi's Letter to the Medivation Board

May 5th 2016

May 05, 2016.

Global Dermatology Market Set to Reach $33.7 Billion by 2022 Despite Patent Expiries

May 4th 2016

May 04, 2016.

Technology

Latest News

Dutch System to Track Biosimilar Use and Switching Announced

Jazz Pharmaceuticals Acquires Celator

Governments on Track to Eliminate Viral Hepatitis by 2030

EMA to Review Safety in First-in-Human Clinical Trials

Valeant Rejected Takeda Bid

Gilead Brings Top Exec Out of Retirement

EFPIA: TTIP Must Go Further to Tackle Regulatory Barriers

Lilly Says Company Could Launch 20 Products in 10 Years

Sanofi Loses Three Top Execs in Reshuffle

EMA Publishes Annual Report

Third Sector "Ready" to Fight Antimicrobial Resistance

NIH to Launch Large-Scale HIV Vaccine Trial

Biopharma Supports Nearly 4.5 Million US Jobs, Says Report

Valeant Holds On to Top Execs with Million-Dollar Bonus Payouts

Pfizer to Acquire Anacor

UK Tops Europe for Regulatory Affairs Vacancies

Vote for Thomson Reuters' Top BioPharma Deals of the Year

Registries and the Future of Medicine

Califf Seeks Evidence to Guide Regulatory Decisions

Takeda Receives Grant from Bill & Melinda Gates Foundation

Opdivo Will Help Boost Non-Small Cell Lung Cancer Market in Asia-Pac

Experts Urge Caution in Expansion of Drug Development Incentive Program

UK Cell and Gene Therapy Manufacturing Capability on the Rise

Sanofi's Letter to the Medivation Board

Global Dermatology Market Set to Reach $33.7 Billion by 2022 Despite Patent Expiries

Trending on PharmExec

The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market

Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion

Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last

Catalent Announces Expanded Partnership with Nanoscope Therapeutics

Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization